SHORT HILLS, N.J.--(BUSINESS WIRE)--Cyclacel Pharmaceuticals, Inc. (Nasdaq: CYCC) (Nasdaq: CYCCP) today reported financial and operating results for the third quarter 2006. The company had a net loss in the quarter of $5.4 million. At the end of the third quarter 2006, the company had $59.7 million in cash, cash equivalents and marketable securities.
